Concepedia

Glen R.B. Irving

GR

Statistics

Publications

5

Citations

696

H-Index

5

Active since

2010

Affiliations

University of Leicester(Current)

Leicester Royal Infirmary

University Hospital of Wales

Glen R.B. Irving is an author at University of Leicester specializing in pharmacology, colorectal cancer, and medicine.

Publications per year

2010–2019

5

Publications

5

Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial

Lynne Howells, Chinenye Iwuji, Glen R.B. Irving et al. · Journal of Nutrition · 2019 · 234 citations · Full text

Medicine, Oncology, Pharmacology +16

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

Mark I. James, Chinenye Iwuji, Glen R.B. Irving et al. · Cancer Letters · 2015 · 182 citations · Full text

Medicine, Oncology, Pharmacology +14

Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability

Glen R.B. Irving, Lynne Howells, Stewart Sale et al. · Cancer Prevention Research · 2012 · 111 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Curcumin ameliorates oxaliplatin‐induced chemoresistance in HCT116 colorectal cancer cells <i>in vitro</i> and <i>in vivo</i>

Lynne Howells, Stewart Sale, Sathya Neelature Sriramareddy et al. · International Journal of Cancer · 2010 · 97 citations · Full text

Medicine, Oncology, Pharmacology +13

Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial

Glen R.B. Irving, Chinenye Iwuji, Bruno Morgan et al. · Trials · 2015 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5